or Try an Advanced Search...

    Technical Analysis for ADAG - Adagene Inc.

    Grade Last Price % Change Price Change
    B 3.05 -0.36% -0.01
    ADAG closed down 0.36 percent on Monday, July 1, 2024, on 33 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Up Up
    Historical ADAG trend table...
    Date Alert Name Type % Chg
    Outside Day Range Expansion 0.00%
    Overbought Stochastic Strength 0.00%
    Gapped Down Weakness 0.00%
    Calm After Storm Range Contraction -0.36%
    Stochastic Reached Overbought Strength -0.36%
    Inside Day Range Contraction -0.36%
    Overbought Stochastic Strength -0.36%
    Gapped Down Weakness -0.36%
    Pocket Pivot Bullish Swing Setup -1.13%
    Upper Bollinger Band Touch Strength -1.13%
    Older End-of-Day Signals for ADAG ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakout about 9 hours ago
    Rose Above Previous Day's High about 9 hours ago
    Outside Day about 9 hours ago
    Up 1% about 9 hours ago
    Down 3% about 10 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    ADAG Chart by TradingView
    Basic chart:

    Profile

    Adagene Inc. is a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies. Adagene combines computational biology and artificial intelligence to design novel antibodies that address unmet patient needs. Its proprietary pipeline is comprised of novel immunotherapy programs. Adagene has forged strategic collaborations with reputable global partners that leverage its technology in multiple approaches at the vanguard of science.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biopharmaceutical Artificial Intelligence Immunology Immunotherapy Antibodies Health Care Cancer Immunotherapy Antibody Virotherapy Immunotherapies

    Is ADAG a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 20 Adagene Inc. (NASDAQ:ADAG) most popular amongst private equity firms who own 39% of the shares, institutions hold 30%
    May 22 Adagene to Present at Investor Conferences in June
    Mar 29 Adagene ADR Non-GAAP EPS of -$0.21, revenue of $18.11M
    Mar 29 Adagene Reports Full Year 2023 Financial Results and Provides Corporate Update
    Mar 7 Adagene Appoints Heinz-Josef Lenz, M.D., FACP to Scientific and Strategic Advisory Board
    Feb 27 Adagene to Present at the Leerink Partners Global Biopharma Conference 2024
    Feb 9 Adagene Announces Progress and Expansion of Clinical Collaboration Program for Masked, Anti-CTLA-4 SAFEbody® ADG126 (muzastotug) in Combination with KEYTRUDA® (pembrolizumab) to Demonstrate Further Efficacy in Patients with Metastatic Microsatellite-st...
    Jan 19 Why TransCode Therapeutics Shares Are Trading Lower By Over 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Jan 18 How Is The Market Feeling About Adagene?
    Jan 17 Adagene falls after trial data for cancer therapy
    See more ADAG news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 4.38
    52 Week Low 1.1001
    Average Volume 38,728
    200-Day Moving Average 2.37
    50-Day Moving Average 2.64
    20-Day Moving Average 2.88
    10-Day Moving Average 2.93
    Average True Range 0.22
    RSI (14) 57.63
    ADX 18.05
    +DI 22.88
    -DI 13.35
    Chandelier Exit (Long, 3 ATRs) 2.52
    Chandelier Exit (Short, 3 ATRs) 3.13
    Upper Bollinger Bands 3.21
    Lower Bollinger Band 2.54
    Percent B (%b) 0.76
    BandWidth 23.37
    MACD Line 0.10
    MACD Signal Line 0.09
    MACD Histogram 0.0163
    Fundamentals Value
    Market Cap 133.7 Million
    Num Shares 43.8 Million
    EPS -0.86
    Price-to-Earnings (P/E) Ratio -3.55
    Price-to-Sales 6.89
    Price-to-Book 1.85
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.28
    Resistance 3 (R3) 3.27 3.18 3.24
    Resistance 2 (R2) 3.18 3.13 3.19 3.22
    Resistance 1 (R1) 3.12 3.09 3.15 3.13 3.21
    Pivot Point 3.03 3.03 3.05 3.04 3.03
    Support 1 (S1) 2.97 2.98 3.00 2.98 2.89
    Support 2 (S2) 2.88 2.94 2.89 2.88
    Support 3 (S3) 2.82 2.88 2.86
    Support 4 (S4) 2.83